Veracyte Inc (VCYT)
Receivables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 445,764 | 361,051 | 296,536 | 219,514 | 117,483 |
Receivables | US$ in thousands | 46,525 | 40,378 | 44,021 | 41,461 | 18,461 |
Receivables turnover | 9.58 | 8.94 | 6.74 | 5.29 | 6.36 |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $445,764K ÷ $46,525K
= 9.58
The receivables turnover ratio for Veracyte Inc. demonstrates a positive trend over the period spanning December 31, 2020, to December 31, 2024. Specifically, the ratio increased from 6.36 times in 2020 to 8.94 times in 2023, indicating an improvement in the company's ability to collect its accounts receivable more efficiently. This upward movement suggests enhanced credit management and faster conversion of receivables into cash.
The ratio further progressed to 9.58 times by December 31, 2024, reflecting continued efficiency gains in receivables collection. An increasing receivables turnover ratio generally signifies shorter collection periods, which can contribute positively to the company's liquidity position. Overall, the trend indicates that Veracyte Inc. has been increasingly effective in managing its receivables, leading to more rapid cash inflows relative to its outstanding receivables over the analyzed period.
Peer comparison
Dec 31, 2024